Bhambi-Blanco, I, González-Alvarez, N, San-José, P. Alder-Reilly Leukocyte Inclusions in a patient with Mucopolysaccharidosis Type VII. ANNALES DE BIOLOGIE CLINIQUE. 2025; 83(-1)DOI:10.1684/abc.2025.1953. PMID:39953854. IF:0.400(Q4/10D).

de Larrea, CF, Loscertales, J, Cabañas, V, Freiria, C, Blanchard, MJ, Askari, E, Perez, ML, Abril, L, Pardo, JL, Pinzón, S, Gálvez, JD, Amer, N, Páyer, AR, Sánchez, RG, Alcalá, MM, Capote, FJ, Moreno, D, Bolumburu, C, Rubio-Azpeitia, E, Sanz, RG. Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain. Therapeutic Advances in Hematology. 2025; 16DOI:10.1177/20406207251379670. PMID:. IF:3.100(Q2/4D).

Döhner, H, Dinardo, CD, Appelbaum, FR, Craddock, C, Dombret, H, Ebert, BL, Fenaux, P, Godley, LA, Hasserjian, RP, Larson, RA, Levine, RL, Miyazaki, Y, Niederwieser, D, Ossenkoppele, G, Röllig, C, Sierra, J, Stein, EM, Tallman, MS, Tien, HF, Wang, JX, Wierzbowska, A, Wei, AH, Löwenberg, B. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. BLOOD. 2024; 144(21)DOI:10.1182/blood.2024025409. PMID:39133932. IF:23.100(Q1/1D).

Salas, MQ, Cascos, E, López-García, A, Pérez, E, Baile-González, M, Rodríguez, CM, Cascón, MJP, Luque, M, Esquirol, A, Fernando, IH, Peña-Muñóz, F, Ormtegi, IO, Marín, AJS, Fernández-Luis, S, Dominguez-García, JJ, Fernández, SV, Girón, MFD, Pinedo, LG, Garcia, L, González-Rodriguez, AP, Torrado, T, Filaferro, S, Cedillo, A, Orti, G, Chacón, MJ. Cardiac events after allo-HCT in patients with acute myeloid leukemia. Blood Advances. 2024; 8(21)DOI:10.1182/bloodadvances.2024013535. PMID:39178345. IF:7.100(Q1/2D).